Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126901301 | 12690130 | 1 | I | 20160710 | 20160817 | 20160826 | 20160826 | EXP | GB-MHRA-EYC 00143683 | GB-BAYER-2016-160461 | BAYER | 66.00 | YR | E | M | Y | 82.00000 | KG | 20160826 | CN | GB | GB |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126901301 | 12690130 | 1 | PS | CIPROFLOXACIN. | CIPROFLOXACIN | 1 | Oral | UNK | N | 19537 | |||||||||
126901301 | 12690130 | 2 | C | ALLOPURINOL. | ALLOPURINOL | 1 | UNK | 0 | |||||||||||
126901301 | 12690130 | 3 | C | ATORVASTATIN | ATORVASTATIN | 1 | UNK | 0 | |||||||||||
126901301 | 12690130 | 4 | C | BISOPROLOL | BISOPROLOL | 1 | UNK | 0 | |||||||||||
126901301 | 12690130 | 5 | C | BUMETANIDE. | BUMETANIDE | 1 | UNK | 0 | |||||||||||
126901301 | 12690130 | 6 | C | CALCICHEW D3 | CALCIUMCHOLECALCIFEROL | 1 | UNK | 0 | |||||||||||
126901301 | 12690130 | 7 | C | FYBOGEL | PLANTAGO OVATA SEED | 1 | UNK | 0 | |||||||||||
126901301 | 12690130 | 8 | C | LANSOPRAZOLE. | LANSOPRAZOLE | 1 | UNK | 0 | |||||||||||
126901301 | 12690130 | 9 | C | MULTIVITAMIN | VITAMINS | 1 | UNK | 0 | |||||||||||
126901301 | 12690130 | 10 | C | PREDNISOLONE. | PREDNISOLONE | 1 | UNK | 0 | |||||||||||
126901301 | 12690130 | 11 | C | PROGRAF | TACROLIMUSTACROLIMUS ANHYDROUS | 1 | UNK | 0 | |||||||||||
126901301 | 12690130 | 12 | C | RISEDRONATE SODIUM. | RISEDRONATE SODIUM | 1 | UNK | 0 | |||||||||||
126901301 | 12690130 | 13 | C | TAUROLIN | TAUROLIDINE | 1 | UNK | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
126901301 | 12690130 | 1 | Neutropenic sepsis |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
126901301 | 12690130 | HO |
126901301 | 12690130 | OT |
126901301 | 12690130 | DS |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
126901301 | 12690130 | Arthralgia | |
126901301 | 12690130 | Tendonitis | |
126901301 | 12690130 | Weight bearing difficulty |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
126901301 | 12690130 | 1 | 20160704 | 20160710 | 0 |